selected scholarly activity
-
conferences
- Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE. Allergy. European Journal of Allergy and Clinical Immunology. 61-61. 2020
- Effect of Intranasal Corticosteroid Treatment on Allergen Induced Changes in Numbers, Activation and Phenotype of Group 2 Innate Lymphoid Cells in Mild Allergic Rhinitics with Asthma. American Journal of Respiratory and Critical Care Medicine. 2020
- Evaluation of the Reproducibility of Nasal Allergen Challenge in Mild Allergic Asthmatics to Support Drug Development. American Journal of Respiratory and Critical Care Medicine. 2020
- Immune thrombocytopenia (ITP) in the setting of hereditary angioedema with C1 inhibitor deficiency (HAE C1INH): a possible consequence of low C4. Journal of Allergy and Clinical Immunology. AB107-AB107. 2020
- Comparison of responses to nasal and whole lung allergen challenges in mild allergic asthmatic subjects with allergic rhinitis. Allergy. European Journal of Allergy and Clinical Immunology. 462-463. 2019
- Co-Occurrence of C1 Esterase Inhibitor Deficiency and Autoimmune Disease: A Systematic Literature Review. Journal of Allergy and Clinical Immunology. AB44-AB44. 2019
- Hereditary Angioedema Rapid Triage Tool (HAE-RT): Translating research into clinical practice. Allergy. European Journal of Allergy and Clinical Immunology. 414-414. 2018
- Aeroallergen and Food Sensitization Patterns in Adults with Eosinophilic Esophagitis. Journal of Allergy and Clinical Immunology. AB230-AB230. 2016
- Multiple Cumulative Allergen Concentration Delivery for Nasal Allergen Challenge – a Refinement of the Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC) Protocol. Journal of Allergy and Clinical Immunology. AB58-AB58. 2015
- INTERNATIONAL PRACTICE OF SELF-ADMINISTRATION IN THE MANAGEMENT OF HEREDITARY ANGIOEDEMA: SURVEY RESULTS AND DISCUSSION FROM AN INTERNATIONAL EXPERT PANEL. Annals of Allergy, Asthma and Immunology. A49-A49. 2013
- THE ALLERGIC RHINITIS CLINICAL INVESTIGATOR COLLABORATIVE-CYTOKINE PROFILING OF SYNTHETIC ABSORPTIVE MATRIX ELUATES TO OPTIMIZE A STANDARD NASAL ALLERGEN CHALLENGE PROTOCOL. Annals of Allergy, Asthma and Immunology. A20-A20. 2013
- Current practice with self-administration in the management of hereditary angioedema: the results of a survey. Allergy. European Journal of Allergy and Clinical Immunology. 613-613. 2013
- The Canadian allergy, genes and environment network of centres of excellence: AllerGen. Allergy. European Journal of Allergy and Clinical Immunology. 287-288. 2013
- The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC) – a Multicentre Pilot Study to Optimize a Standard Nasal Allergen Challenge Protocol. Journal of Allergy and Clinical Immunology. AB135-AB135. 2013
- Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema. International Archives of Allergy and Immunology. 10-16. 2013
- The Allergic Rhinitis Clinical Investigator Collaborative (ar-Cic) - Optimization Of Screening Nasal Allergen Challenge For Use In Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 2013
- Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis. Allergy. European Journal of Allergy and Clinical Immunology. 243-244. 2011
- Canadian clinical practice guidelines for acute and chronic rhinosinusitis.. Journal of Otolaryngology - Head and Neck Surgery. S99-193. 2011
- Case report of recurrent throat swelling due to hereditary angioedema despite prophylaxis treated with icatibant. Allergy. European Journal of Allergy and Clinical Immunology. 600-600. 2010
- Significant Reduction In Combined Symptom And Medication Score Compared With Placebo With A Ragweed uSCIT Formulation For Seasonal Pollen Allergy. Journal of Allergy and Clinical Immunology. 731-731. 2009
- A Double-blind, Placebo-controlled, Randomized, Crossover Trial Of a Mint Tea High In Rosmarinic Acid In Adults With Nasal Polyposis. Journal of Allergy and Clinical Immunology. S202-S202. 2009
- Significant Improvements In Quality Of Life Following MPL-Adjuvanted Ultra Short Course Subcutaneous Immunotherapy (uSCIT) In Patients With Seasonal Grass Pollen Allergy. Journal of Allergy and Clinical Immunology. S61-S61. 2009
- Air Filtration for Childhood Asthma: A Pilot Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 2009
- Consistency of effect of fluticasone furoate nasal spray on nasal and ocular symptoms of seasonal allergic rhinitis. Allergy. European Journal of Allergy and Clinical Immunology. 132-132. 2009
- Fluticasone furoate nasal spray improves the individual nasal symptoms (rhinorrhoea, nasal congestion, nasal itching, sneezing) of seasonal allergic rhinitis across four studies. Allergy. European Journal of Allergy and Clinical Immunology. 131-132. 2009
- Quality of life benefits for patients with seasonal grass pollen-allergic rhinoconjunctivitis receiving ultra short course subcutaneous immunotherapy (uSCIT) with MPL adjuvant. Allergy. European Journal of Allergy and Clinical Immunology. 348-348. 2009
- Validation of the Asthma Control Questionnaire in Children.. American Journal of Respiratory and Critical Care Medicine. 2009
- Changes in Upper and Lower Airway Inflammation Following Repeated Nasal Allergen Challenges in Rhinitic Subjects With or Without Asthma. Journal of Allergy and Clinical Immunology. S200-S200. 2008
- Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma. Annals of Allergy, Asthma and Immunology. A84-A84. 2008
- Desloratadine significantly reduces nasal congestion and other individual symptoms scores in subjects with intermittent allergic rhinitis: The ACCEPT1 Study in collaboration with GA(2)LEN. Allergy. European Journal of Allergy and Clinical Immunology. 634-634. 2008
- Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma. Allergy. European Journal of Allergy and Clinical Immunology. 553-553. 2007
- The development of serum IgE test panels for use by Canadian primary care physicians. Allergy. European Journal of Allergy and Clinical Immunology. 148-148. 2007
- Allergies in Canada: AR Patient Perspectives on Prescription Nasal Sprays. Journal of Allergy and Clinical Immunology. S226-S226. 2007
- Burden of Illness of Allergic Rhinitis in Canada. Journal of Allergy and Clinical Immunology. S227-S227. 2007
- Physicians' Perspectives of Allergic Rhinitis (AR) in Canada. Journal of Allergy and Clinical Immunology. S226-S226. 2007
- The treatment of bilateral nasal polyposis with fluticasone propionate nasal drops.. Journal of Allergy and Clinical Immunology. S115-S115. 1999
- Experiences of a latex allergy work group.. Journal of Allergy and Clinical Immunology. S204-S204. 1998
- Rate of MMR associated reactions in patients following positive prick and intradermal testing.. Journal of Allergy and Clinical Immunology. S50-S50. 1998
- A cost-benefit analysis of a medical therapy for seasonal allergic rhinitis.. Journal of Allergy and Clinical Immunology. 1791-1791. 1997
- A DOUBLE-BLIND COMPARISON OF INTRANASAL BUDESONIDE DRY POWDER VS PLACEBO IN NASAL POLYPOSIS. Journal of Allergy and Clinical Immunology. 204-204. 1995
- RHINOCORT(R) TURBUHALER(R) HAS EQUAL EFFICACY AND BETTER PATIENTS PREFERENCE THAN RHINOCORT(R) AQUA IN THE TREATMENT OF RAGWEED ALLERGIC RHINITIS. Journal of Allergy and Clinical Immunology. 195-195. 1995
- A CONTROLLED TRIAL OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR (RHU-IL-1R) FOR GRASS-POLLEN HAY-FEVER. Journal of Allergy and Clinical Immunology. 297-297. 1994
- SEASONAL EXPOSURE IN RAGWEED ALLERGIC NASAL POLYP PATIENTS - 1) LACK OF SYMPTOMS, 2) MEASUREMENT OF POSSIBLE INHIBITORS, NASAL IL-8 AND SIL-1R. Journal of Allergy and Clinical Immunology. 216-216. 1994
- TISSUE PRODUCTION OF CYTOKINES IN ALLERGY. PROGRESS IN ALLERGY AND CLINICAL IMMUNOLOGY, VOL 2, KYOTO. 513-517. 1992
-
journal articles
- Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study.. Acta Allergologica. 2024
- Infusion parameters, safety, and practical guidance for the manual administration of subcutaneous immunoglobulin 20% (Ig20Gly).. Allergy, Asthma and Clinical Immunology. 20:52. 2024
- Comparison of upper and lower airway expression of SARS‐COV‐2 receptors in allergic asthma. Acta Allergologica. 79:2856-2858. 2024
- Focused allergic rhinitis practice parameter for Canada. Allergy, Asthma and Clinical Immunology. 20:45. 2024
- Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study. The Lancet Haematology. 11:e436-e447. 2024
- Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids. Clinical and Experimental Allergy. 53:1187-1197. 2023
-
Protein expression of
SARS‐CoV ‐2 receptorsACE2 andTMPRSS2 in allergic airways after allergen challenge. Acta Allergologica. 78:3010-3013. 2023 - Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study. Allergy, Asthma and Clinical Immunology. 19:54. 2023
- A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis. Allergy, Asthma and Clinical Immunology. 19:48. 2023
- Canadian multidisciplinary expert consensus on the use of biologics in upper airways: A Delphi study. Journal of Otolaryngology - Head and Neck Surgery. 52:30. 2023
- Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study. Allergy, Asthma and Clinical Immunology. 18:70. 2022
- Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. 399:945-955. 2022
- Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet Journal of Rare Diseases. 16:329. 2021
- Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet Journal of Rare Diseases. 16:86. 2021
- Effect of intranasal corticosteroid treatment on allergen‐induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma. Acta Allergologica. 76:2797-2808. 2021
- Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters. Thrombosis and Haemostasis. 121:690-693. 2021
- Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19. Acta Allergologica. 76:735-750. 2021
- MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review. International Archives of Allergy and Immunology. 182:1026-1035. 2021
- Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review. Allergy, Asthma and Clinical Immunology. 16:41. 2020
- Correction to: The International/Canadian Hereditary Angioedema Guideline. Allergy, Asthma and Clinical Immunology. 16:33. 2020
- Is diet partly responsible for differences in COVID-19 death rates between and within countries?. Clinical and Translational Allergy. 10:16. 2020
- Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies. Clinical and Translational Allergy. 10:58. 2020
- Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review. Allergy, Asthma and Clinical Immunology. 16:72. 2020
- Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air®App. Acta Allergologica. 75:1672-1688. 2020
- Development of the Hereditary Angioedema Rapid Triage Tool. Journal of Allergy and Clinical Immunology: In Practice. 8:310-317.e3. 2020
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clinical and Translational Allergy. 9:16. 2019
- The International/Canadian Hereditary Angioedema Guideline. Allergy, Asthma and Clinical Immunology. 15:72. 2019
- Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. Journal of Allergy and Clinical Immunology: In Practice. 7:1793-1802.e2. 2019
- Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study. Journal of Allergy and Clinical Immunology: In Practice. 7:1610-1618.e4. 2019
-
Adherence to treatment in allergic rhinitis using mobile technology. The
MASK Study. Clinical and Experimental Allergy. 49:442-460. 2019 - Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology. 143:864-879. 2019
- MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clinical and Translational Allergy. 8:45. 2018
- Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema. Clinical and Experimental Allergy. 48:1325-1332. 2018
- Allergic rhinitis. Allergy, Asthma and Clinical Immunology. 14:51. 2018
- Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. Journal of Allergy and Clinical Immunology: In Practice. 6:1733-1741.e3. 2018
- ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2:78-83. 2018
- Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy. 7:5. 2017
-
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A
EUFOREA ‐ARIA ‐EPOS ‐AIRWAYS ICP statement. Acta Allergologica. 72:1297-1305. 2017 - Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. New England Journal of Medicine. 376:1131-1140. 2017
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clinical and Translational Allergy. 6:47. 2016
- Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy. 6:29. 2016
- MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. Journal of Allergy and Clinical Immunology. 138:367-374.e2. 2016
- The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. Allergy, Asthma and Clinical Immunology. 11:16. 2015
- MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Acta Allergologica. 70:1372-1392. 2015
- 10th anniversary of allergy, asthma & clinical immunology. Allergy, Asthma and Clinical Immunology. 10:51. 2014
- Canadian hereditary angioedema guideline. Allergy, Asthma and Clinical Immunology. 10:50. 2014
- The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC) - optimizing the Nasal Allergen Challenge (NAC) model. Allergy, Asthma and Clinical Immunology. 10:a62. 2014
- Beurteilung der Wirksamkeit der spezifischen Immuntherapie anhand einer neuartigen Methode auf der Basis des Plazebo-Scores. Allergologie. 36:1-10. 2013
- The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients. Allergy, Asthma and Clinical Immunology. 8:7. 2012
- Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology. 130:1049-1062. 2012
- Assessment of specific immunotherapy efficacy using a novel placebo score–based method. Annals of Allergy, Asthma and Immunology. 109:342-347.e1. 2012
- Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study. Primary Care Respiratory Journal. 21:267-275. 2012
- Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, Asthma and Clinical Immunology. 7:2. 2011
- Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma. Allergy, Asthma and Clinical Immunology. 7:8. 2011
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. Allergy and Asthma Proceedings. 32:466-466. 2011
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. Allergy and Asthma Proceedings. 32:239-247. 2011
- Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently. Journal of Allergy and Clinical Immunology. 127:288-289. 2011
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy, Asthma and Clinical Immunology. 6:24. 2010
- Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper. Acta Allergologica. 65:1212-1221. 2010
- World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatric Allergy and Immunology. 21:1-125. 2010
- Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?. Current Medical Research and Opinion. 26:1139-1140. 2010
- Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Reply. Current Medical Research and Opinion. 26:1140-1140. 2010
- Erratum. Current Medical Research and Opinion. 26:990-990. 2010
- Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA<sup>2</sup>LEN Study. International Archives of Allergy and Immunology. 153:395-402. 2010
- World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organization Journal. 3:57-161. 2010
- OCULAR SYMPTOM EFFICACY AND INTRANASAL CORTICOSTEROIDS. Annals of Allergy, Asthma and Immunology. 103:539-539. 2009
- Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Acta Allergologica. 64:1516-1523. 2009
- Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?. Current Medical Research and Opinion. 25:2021-2041. 2009
- Fragrance sensitivity article questioned.. Journal of Environmental Health. 71:51-52. 2009
- Montelukast as Add-On Therapy with Inhaled Corticosteroids Alone or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (the RADAR Trial). Canadian Respiratory Journal. 16:17A-24A. 2009
- Eosinophil Progenitors in Airway Diseases. Chest. 134:1037-1043. 2008
- Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data. Expert Opinion on Pharmacotherapy. 9:2707-2715. 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*. Acta Allergologica. 63:8-160. 2008
- Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Annals of Allergy, Asthma and Immunology. 100:S30-S40. 2008
- Hereditary angiodema:: a current state-of-the-art review, VII:: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Annals of Allergy, Asthma and Immunology. 100:S30-S40. 2008
- Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study. Clinical Therapeutics. 29:1390-1402. 2007
- Rhinitis: A Practical and Comprehensive Approach to Assessment and Therapy. Journal of Otolaryngology - Head and Neck Surgery. 36:S5-S5. 2007
- Rhinitis: An Executive Summary of a Practical and Comprehensive Approach to Assessment and Therapy. Journal of Otolaryngology - Head and Neck Surgery. 36:S1-S1. 2007
- Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial. Clinical Therapeutics. 29:419-426. 2007
- Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: Results of a Canadian multicenter, open-label trial. Clinical Therapeutics. 29:419-426. 2007
- Nonallergic rhinitis with eosinophilia syndrome and related disorders.. Clinical allergy and immunology. 19:87-100. 2007
- Nonallergic rhinitis with eosinophilia syndrome. Current Allergy and Asthma Reports. 6:215-220. 2006
- The Effect of Desloratadine on Eosinophil/Basophil Progenitors and Other Inflammatory Markers in Seasonal Allergic Rhinitis: A Placebo-Controlled Randomized Study. International Archives of Allergy and Immunology. 138:209-216. 2005
- The September epidemic of asthma exacerbations in children: A search for etiology. Journal of Allergy and Clinical Immunology. 115:132-138. 2005
- Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. Annals of Allergy, Asthma and Immunology. 93:425-430. 2004
- Systemic aspects of chronic rhinosinusitis. Immunology and Allergy Clinics of North America. 24:87-102. 2004
- Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology. 90:214-222. 2003
- Food– and exercise-induced anaphylaxis: importance of history in diagnosis. Annals of Allergy, Asthma and Immunology. 89:15-23. 2002
- Probiotics in the Management and Prevention of Atopy. Clinical Reviews in Allergy and Immunology. 22:275-286. 2002
- Probiotics in the management and prevention of atopy. Clinical Reviews in Allergy and Immunology. 22:275-285. 2002
- Repeatability and validity of cell and fluid‐phase measurements in nasal fluid: a comparison of two methods of nasal lavage. Clinical and Experimental Allergy. 31:1111-1115. 2001
- Linear IgA dermatosis: An unusual case involving the oral mucosa and possible association with perindopril therapy. Allergy, Asthma and Clinical Immunology. 5:203-208. 2000
- Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults. Clinical and Experimental Allergy. 30:1460-1468. 2000
- A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology. 84:55-62. 2000
- Stroke following intravenous immunoglobulin infusion in a 28-year-old male with common variable immune deficiency: A case report and literature review. Allergy, Asthma and Clinical Immunology. 4:250-253. 1999
- Incidence of latex sensitization among latex glove users.. Journal of Allergy and Clinical Immunology. 101:171-178. 1998
- Incidence of latex sensitization among latex glove users☆☆☆★★★. Journal of Allergy and Clinical Immunology. 101:171-178. 1998
- Comparison of Budesonide Turbuhaler with Budesonide Aqua in the Treatment of Seasonal Allergic Rhinitis. Canadian Respiratory Journal. 5:455-460. 1998
- Nasal polyps: Effects of seasonal allergen exposure. Journal of Allergy and Clinical Immunology. 93:567-574. 1994
- ANAPHYLACTIC AND ANAPHYLACTOID REACTIONS IN THE PERIOPERATIVE PERIOD. Immunology and Allergy Clinics of North America. 12:671-690. 1992